• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贾第虫病、耐药性与新靶点发现

Giardiasis, drug resistance, and new target discovery.

作者信息

Tian Hai-Feng, Chen Bing, Wen Jian-Fan

机构信息

State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences (CAS), Kunming, Yunnan Province 650223, China.

出版信息

Infect Disord Drug Targets. 2010 Aug;10(4):295-302. doi: 10.2174/187152610791591629.

DOI:10.2174/187152610791591629
PMID:20429862
Abstract

Giardiasis is a worldwide parasitic disease caused by the protozoan Giardia lamblia in humans and other animals, especially live stocks. Here, we briefly review the current state of therapeutic availability for giardiasis, including chemical drugs and vaccines, and the dilemma in the prevention and treatment of this disease, including the emergence of drug resistance and the shortage of vaccine (especially for humans). Future efforts and progress in controlling giardiasis are expected in three aspects: clarification of the drug resistance mechanisms, development of efficient vaccines, and identification of more targets for new drugs and vaccines.

摘要

贾第虫病是一种由原生动物蓝氏贾第鞭毛虫引起的全球性寄生虫病,可感染人类和其他动物,尤其是家畜。在此,我们简要回顾一下贾第虫病目前的治疗方法,包括化学药物和疫苗,以及该疾病在预防和治疗方面所面临的困境,包括耐药性的出现和疫苗短缺(尤其是针对人类的疫苗)。预计在控制贾第虫病方面未来将在三个方面取得进展:阐明耐药机制、开发高效疫苗以及确定更多新药和疫苗的靶点。

相似文献

1
Giardiasis, drug resistance, and new target discovery.贾第虫病、耐药性与新靶点发现
Infect Disord Drug Targets. 2010 Aug;10(4):295-302. doi: 10.2174/187152610791591629.
2
Giardiasis: recent progress in chemotherapy and drug development.贾第虫病:化疗与药物研发的最新进展
Curr Pharm Des. 2003;9(11):841-55. doi: 10.2174/1381612033455260.
3
Treatment of patients with refractory giardiasis.难治性贾第虫病患者的治疗
Clin Infect Dis. 2001 Jul 1;33(1):22-8. doi: 10.1086/320886. Epub 2001 May 23.
4
Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.后基因组时代的贾第虫病:治疗、耐药性及新的治疗前景
Infect Disord Drug Targets. 2010 Aug;10(4):283-94. doi: 10.2174/187152610791591610.
5
Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.硝咪唑类药物难治性贾第虫病:一个日益严重的问题,需要合理的解决方案。
Clin Microbiol Infect. 2018 Jan;24(1):37-42. doi: 10.1016/j.cmi.2017.05.028. Epub 2017 Jun 15.
6
Discovery of novel antigiardiasis drug candidates.新型抗贾第虫病候选药物的发现。
Antimicrob Agents Chemother. 2014 Dec;58(12):7303-11. doi: 10.1128/AAC.03834-14. Epub 2014 Sep 29.
7
Giardiasis: report of a case refractory to treatment.贾第虫病:一例难治性病例报告。
Infez Med. 2019 Sep 1;27(3):336-339.
8
Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.布拉氏酵母菌在实验性贾第虫病中的治疗选择。
J Appl Microbiol. 2021 Jul;131(1):460-469. doi: 10.1111/jam.14941. Epub 2020 Dec 9.
9
Spontaneous Resolution of Pancreatic Cyst After Treatment for Giardiasis.贾第虫病治疗后胰腺囊肿的自发消退
Pancreas. 2017 Feb;46(2):e14-e15. doi: 10.1097/MPA.0000000000000706.
10
Aminosidine sulphate in experimental giardiasis.硫酸氨基糖苷在实验性贾第虫病中的作用
J Egypt Soc Parasitol. 1995 Apr;25(1):53-61.

引用本文的文献

1
Nitazoxanide Analogs: Synthesis, In Vitro Giardicidal Activity, and Effects on Metabolic Gene Expression.硝唑尼特类似物:合成、体外抗贾第虫活性及对代谢基因表达的影响
Int J Mol Sci. 2025 May 8;26(10):4504. doi: 10.3390/ijms26104504.
2
The NLRP3 inflammasome recognizes alpha-2 and alpha-7.3 giardins and decreases the pathogenicity of Giardia duodenalis in mice.NLRP3 炎性小体识别α-2 和 α-7.3 贾第鞭毛虫,并降低小鼠中十二指肠贾第鞭毛虫的致病性。
Parasit Vectors. 2023 Mar 3;16(1):85. doi: 10.1186/s13071-023-05688-2.
3
Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazole.
十二指肠贾第虫:黄血蛋白参与药物生物转化和对阿苯达唑的耐药性。
PLoS Pathog. 2022 Sep 27;18(9):e1010840. doi: 10.1371/journal.ppat.1010840. eCollection 2022 Sep.
4
Linn leaf ethanolic extract: In vivo giardicidal potential with ultrastructural damage, anti-inflammatory and antioxidant effects.林恩叶乙醇提取物:具有超微结构损伤、抗炎和抗氧化作用的体内抗贾第虫潜力。
Saudi J Biol Sci. 2021 Jan;28(1):427-439. doi: 10.1016/j.sjbs.2020.10.026. Epub 2020 Oct 27.
5
Identification of a TRBD zinc finger-interacting protein in Giardia duodenalis and its regulation of telomerase.鉴定十二指肠贾第鞭毛虫中与 TRBD 锌指蛋白相互作用的蛋白及其对端粒酶的调控作用。
Parasit Vectors. 2019 Nov 29;12(1):568. doi: 10.1186/s13071-019-3821-0.
6
Structure-based identification of a potential non-catalytic binding site for rational drug design in the fructose 1,6-biphosphate aldolase from Giardia lamblia.基于结构的鉴定:蓝氏贾第鞭毛虫果糖 1,6-二磷酸醛缩酶中潜在非催化结合位点用于合理药物设计。
Sci Rep. 2019 Aug 13;9(1):11779. doi: 10.1038/s41598-019-48192-3.
7
Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical assemblage A and B isolates.临床A群和B群分离株中甲硝唑代谢和氧化应激途径的基因变异。
Infect Drug Resist. 2019 May 10;12:1221-1235. doi: 10.2147/IDR.S177997. eCollection 2019.
8
In vitro and ex vivo evaluation of the anti-Giardia duodenalis activity of the supernatant of Slab51 (SivoMixx).Slab51(SivoMixx)上清液抗十二指肠贾第鞭毛虫体外和离体活性的评价。
PLoS One. 2019 Mar 7;14(3):e0213385. doi: 10.1371/journal.pone.0213385. eCollection 2019.
9
Anti-giardial therapeutic potential of dichloromethane extracts of Zingiber officinale and Curcuma longa in vitro and in vivo.姜和姜黄二氯甲烷提取物对贾第虫的体内外抗虫治疗潜力
Parasitol Res. 2016 Jul;115(7):2637-45. doi: 10.1007/s00436-016-5010-9. Epub 2016 Mar 16.
10
Albendazole induces oxidative stress and DNA damage in the parasitic protozoan Giardia duodenalis.阿苯达唑可诱导寄生原生动物十二指肠贾第鞭毛虫产生氧化应激和DNA损伤。
Front Microbiol. 2015 Aug 6;6:800. doi: 10.3389/fmicb.2015.00800. eCollection 2015.